Source: Basic and Clinical Pharmacology and Toxicology. Unidade: FMRP
Subjects: FARMACOGENÉTICA, GENÉTICA, POLIMORFISMO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAMAMOTO, Priscila A. et al. Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms. Basic and Clinical Pharmacology and Toxicology, v. 124, n. 3, p. 266-272, 2019Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13126. Acesso em: 15 maio 2024.APA
Yamamoto, P. A., Benzi, J. R. L., Azeredo, F. J., Dach, F., Ianhez Júnior, E., Zanelli, C. F., & Moraes, N. V. de. (2019). Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms. Basic and Clinical Pharmacology and Toxicology, 124( 3), 266-272. doi:10.1111/bcpt.13126NLM
Yamamoto PA, Benzi JRL, Azeredo FJ, Dach F, Ianhez Júnior E, Zanelli CF, Moraes NV de. Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms [Internet]. Basic and Clinical Pharmacology and Toxicology. 2019 ; 124( 3): 266-272.[citado 2024 maio 15 ] Available from: https://doi.org/10.1111/bcpt.13126Vancouver
Yamamoto PA, Benzi JRL, Azeredo FJ, Dach F, Ianhez Júnior E, Zanelli CF, Moraes NV de. Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms [Internet]. Basic and Clinical Pharmacology and Toxicology. 2019 ; 124( 3): 266-272.[citado 2024 maio 15 ] Available from: https://doi.org/10.1111/bcpt.13126
